** Shares of Aroa Biosurgery ARX.AX fall 18.1% to A$0.655, on track for their biggest-ever intraday drop
** Wound healing products maker fell as much as 19.1% earlier in the day, hitting lowest level since Dec. 18
** Co cuts FY25 normalised EBITDA profit guidance to a range between NZ$2 mln ($1.13 mln) and NZ$4 mln, from earlier guidance of NZ$2 mln to NZ$6 mln
** Cuts FY25 total revenue guidance to between NZ$81 mln and NZ$84 mln from earlier guidance of NZ$80 mln to NZ$87 mln
** About 901,488 shares change hand, compared to 30-day average trading volume of 318,195 shares
** Stock down around 15% this year, including the day's moves
($1 = 1.7680 New Zealand dollars)
(Reporting by John Biju in Bengaluru)
((John.Biju@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.